Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?
Bakker
J A
JA
Department of Clinical Genetics, ILD Care Team, University Hospital Maastricht, 6202 AZ, Maastricht, The Netherlands. jaap.bakker@gen.unimaas.nl
Bierau
J
J
Drent
M
M
D001379:Azathioprine / Q000009:adverse effects*; D005820:Genetic Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000188:drug therapy* / Q000235:genetics*; D008780:Methyltransferases / Q000172:deficiency / Q000235:genetics; D010597:Pharmacogenetics
D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine